Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
1.030
-0.080 (-7.21%)
At close: Nov 7, 2024, 4:00 PM
1.080
+0.050 (4.85%)
After-hours: Nov 7, 2024, 6:07 PM EST
Carisma Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -72.5 | -86.88 | -61.23 | -40.78 | -28.35 |
Depreciation & Amortization | 3.37 | 2.84 | 1.89 | 0.68 | 0.45 |
Other Amortization | - | 1.28 | 2.54 | - | - |
Loss (Gain) From Sale of Assets | 0.16 | 0.16 | - | - | - |
Loss (Gain) From Sale of Investments | -0.54 | -1.11 | - | - | - |
Stock-Based Compensation | 3.4 | 2.32 | 0.28 | 0.48 | 0.16 |
Other Operating Activities | 7.54 | 5.65 | 6.21 | 0.83 | 1.18 |
Change in Accounts Payable | -0.37 | 2.19 | -0.47 | -0.97 | 1.28 |
Change in Unearned Revenue | -4.51 | -1.05 | 47.46 | - | - |
Change in Other Net Operating Assets | -12.26 | -6.58 | -1.79 | 2.44 | -1.74 |
Operating Cash Flow | -75.64 | -81.18 | -5.12 | -37.33 | -27.01 |
Capital Expenditures | -0.87 | -1.13 | -4.66 | -1.87 | -0.44 |
Investment in Securities | 41 | 73.54 | -27.9 | - | - |
Investing Cash Flow | 40.13 | 72.41 | -32.56 | -1.87 | -0.44 |
Long-Term Debt Issued | - | 1.18 | 36.63 | - | - |
Long-Term Debt Repaid | - | -2.37 | -0.96 | - | - |
Net Debt Issued (Repaid) | -2.77 | -1.19 | 35.66 | - | - |
Issuance of Common Stock | 3.02 | 31.42 | 0.11 | - | 0.02 |
Other Financing Activities | -0.76 | 31.94 | -2.45 | -0.37 | - |
Financing Cash Flow | -0.51 | 62.18 | 33.32 | 15.96 | 72.26 |
Net Cash Flow | -36.02 | 53.41 | -4.36 | -23.24 | 44.81 |
Free Cash Flow | -76.51 | -82.31 | -9.78 | -39.2 | -27.45 |
Free Cash Flow Margin | -369.45% | -551.71% | -99.41% | - | - |
Free Cash Flow Per Share | -1.87 | -2.46 | -4.59 | -36.16 | -25.82 |
Cash Interest Paid | 0.37 | 0.35 | 0.1 | - | - |
Levered Free Cash Flow | -46.39 | -51.52 | -30.1 | -24.24 | - |
Unlevered Free Cash Flow | -46.39 | -52.8 | -30.68 | -24.24 | - |
Change in Net Working Capital | 4.81 | 1.37 | -6.92 | -1.97 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.